Role of albiglutide in the treatment of type 2 diabetes. Issue 6 (June 2016) - Chaplin, Steve
Abstract : Albiglutide (Eperzan) is a GLP‐1 agonist licensed for the treatment of type 2 diabetes in adults to improve glycaemic control. This article discusses its indications, efficacy and adverse effects.